TY  - JOUR
TI  - CLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY
N2  - Immune microthrombovasculitis (IMTV) is a rare disorder characterized by immune-mediated microvascular thrombosis, often requiring anticoagulant therapy to mitigate thrombotic complications. This prospective study investigates the dynamics of hemostatic system parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and biomarkers (von Willebrand factor [vWF], C-reactive protein [CRP]) in 40 patients with IMTV over a 12-month period. Patients received either warfarin or direct oral anticoagulants (DOACs). Significant reductions in D-dimer levels (from 1.3 µg/mL to 0.5 µg/mL, p<0.01) and stabilization of APTT were observed in 85% of DOAC-treated patients. Fibrinogen levels remained elevated in 55% of patients, correlating with CRP (r=0.68, p<0.01). Elevated vWF levels at baseline (185 IU/dL) decreased modestly (145 IU/dL, p=0.04), reflecting partial endothelial recovery. Persistent vWF elevation was associated with a 20% incidence of recurrent thrombotic events. These findings underscore the utility of hemostatic parameters and biomarkers in monitoring therapy efficacy and predicting outcomes, advocating for personalized treatment strategies in IMTV.
PB  - Center for Tech and Media Research
N1  - Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/3958)
JF  - Multidisciplinary Journal of Science and Technology
AV  - none
ID  - arxiv60183
Y1  - 2025/06/09/
UR  - https://mjstjournal.com/index.php/mjst/article/view/3958
KW  - Immune microthrombovasculitis
KW  -  anticoagulant therapy
KW  -  hemostatic parameters
KW  -  D-dimer
KW  -  fibrinogen
KW  -  von Willebrand factor
KW  -  C-reactive protein.
A1  - Kurbanova, Z.Ch.
A1  - Z.A, Sayfuddinova
A1  - Begmatova3, .A.
ER  -